As of April 2, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, marking an explosive start to the year with 17 new outbreaks and 94% of cases outbreak-associated, many spilling over from 2025's record 2,286 infections. This surge stems from declining MMR vaccination coverage—now 92.5% among kindergartners, below the 95% herd immunity threshold—coupled with importations from global hotspots fueling rapid spread (R0 of 12–18) in unvaccinated communities, where 92% of cases occur. Hospitalizations affect 5% of patients, with zero deaths to date. Weekly CDC surveillance updates on Thursdays will track transmission dynamics, vaccination drives, and containment efforts critical to projecting full-year totals.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourCas de rougeole aux États-Unis en 2026 ?
Cas de rougeole aux États-Unis en 2026 ?
$7,503,966 Vol.
$7,503,966 Vol.
31 déc. 2026
↑2k
99%
↑3k
88%
↑4k
68%
↑5k
49%
↑7,5k
22%
↑10k
18%
↑12,5k
11%
$7,503,966 Vol.
$7,503,966 Vol.
31 déc. 2026
↑2k
$36,083 Vol.
99%
↑3k
$27,725 Vol.
88%
↑4k
$131,712 Vol.
68%
↑5k
$188,901 Vol.
49%
↑7,5k
$153,685 Vol.
22%
↑10k
$6,474,738 Vol.
18%
↑12,5k
$316,358 Vol.
11%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 2, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, marking an explosive start to the year with 17 new outbreaks and 94% of cases outbreak-associated, many spilling over from 2025's record 2,286 infections. This surge stems from declining MMR vaccination coverage—now 92.5% among kindergartners, below the 95% herd immunity threshold—coupled with importations from global hotspots fueling rapid spread (R0 of 12–18) in unvaccinated communities, where 92% of cases occur. Hospitalizations affect 5% of patients, with zero deaths to date. Weekly CDC surveillance updates on Thursdays will track transmission dynamics, vaccination drives, and containment efforts critical to projecting full-year totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Jan 23, 2026, 1:46 PM ET
Volume
$7,503,966Date de fin
31 déc. 2026Marché ouvert
Jan 23, 2026, 1:46 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 2, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, marking an explosive start to the year with 17 new outbreaks and 94% of cases outbreak-associated, many spilling over from 2025's record 2,286 infections. This surge stems from declining MMR vaccination coverage—now 92.5% among kindergartners, below the 95% herd immunity threshold—coupled with importations from global hotspots fueling rapid spread (R0 of 12–18) in unvaccinated communities, where 92% of cases occur. Hospitalizations affect 5% of patients, with zero deaths to date. Weekly CDC surveillance updates on Thursdays will track transmission dynamics, vaccination drives, and containment efforts critical to projecting full-year totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,503,966Date de fin
31 déc. 2026Marché ouvert
Jan 23, 2026, 1:46 PM ETResolver
0x65070BE91...As of April 2, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,671 confirmed measles cases across 33 U.S. jurisdictions, marking an explosive start to the year with 17 new outbreaks and 94% of cases outbreak-associated, many spilling over from 2025's record 2,286 infections. This surge stems from declining MMR vaccination coverage—now 92.5% among kindergartners, below the 95% herd immunity threshold—coupled with importations from global hotspots fueling rapid spread (R0 of 12–18) in unvaccinated communities, where 92% of cases occur. Hospitalizations affect 5% of patients, with zero deaths to date. Weekly CDC surveillance updates on Thursdays will track transmission dynamics, vaccination drives, and containment efforts critical to projecting full-year totals.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes